Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Daily Top 10 COVID-19 papers

DEU | ENG | ESP | FRA | ITA | POR | TUR | VNM


  Parkinson's Disease

  Free Subscription


Articles published in Neurosci Lett

Retrieve available abstracts of 191 articles:
HTML format



Single Articles


    May 2020
  1. LIU HJ, Li XY, Chen H, Yu HL, et al
    Identification of susceptibility loci for cognitive impairment in a cohort of Han Chinese patients with Parkinson's disease.
    Neurosci Lett. 2020 May 10:135034. doi: 10.1016/j.neulet.2020.135034.
    PubMed     Abstract available


    April 2020
  2. WANG J, Liu Y, Liu Y, Zhu K, et al
    The association between TLR3 rs3775290 polymorphism and sporadic Parkinson's disease in Chinese Han population.
    Neurosci Lett. 2020 Apr 23:135005. doi: 10.1016/j.neulet.2020.135005.
    PubMed     Abstract available


  3. QIU X, Huang Y, Cen L, Chen X, et al
    Association of GLP-1 receptor gene polymorphisms with sporadic Parkinson's disease in Chinese Han population.
    Neurosci Lett. 2020 Apr 22:135004. doi: 10.1016/j.neulet.2020.135004.
    PubMed     Abstract available


  4. JIN X, Li J, Li W, Wang X, et al
    Weighted gene co-expression network analysis reveals specific modules and biomarkers in Parkinson's Disease.
    Neurosci Lett. 2020 Apr 7:134950. doi: 10.1016/j.neulet.2020.134950.
    PubMed     Abstract available


    March 2020
  5. KOSKI SK, Leino S, Panula P, Rannanpaa S, et al
    Genetic lack of histamine upregulates dopamine neurotransmission and alters rotational behavior but not levodopa-induced dyskinesia in a mouse model of Parkinson's disease.
    Neurosci Lett. 2020 Mar 26:134932. doi: 10.1016/j.neulet.2020.134932.
    PubMed     Abstract available


  6. XU X, Xiong S, Zhou X, Chen X, et al
    SAP97 polymorphisms is associated with early onset Parkinson's disease.
    Neurosci Lett. 2020 Mar 26:134931. doi: 10.1016/j.neulet.2020.134931.
    PubMed     Abstract available


  7. HU X, Mao C, Hu Z, Zhang Z, et al
    Association Analysis of 15 GWAS-linked Loci with Parkinson's Disease in Chinese Han Population.
    Neurosci Lett. 2020 Mar 9:134867. doi: 10.1016/j.neulet.2020.134867.
    PubMed     Abstract available


    February 2020
  8. ZHANG X, Xue L, Sun X, Jin J, et al
    Association of IL-16 gene polymorphisms with sporadic Parkinson's disease in a Han Chinese population.
    Neurosci Lett. 2020 Feb 28:134877. doi: 10.1016/j.neulet.2020.134877.
    PubMed     Abstract available


  9. SONG G, Xi G, Li Y, Zhao Y, et al
    Double triggers, nasal induction of a Parkinson's disease mouse model.
    Neurosci Lett. 2020;724:134869.
    PubMed     Abstract available


  10. WANG MD, Yao YN, Tang XC, Tang B, et al
    Reduced plasma progranulin levels are associated with the severity of Parkinson's disease.
    Neurosci Lett. 2020 Feb 26:134873. doi: 10.1016/j.neulet.2020.134873.
    PubMed     Abstract available


  11. HANOGLU L, Saricaoglu M, Toprak G, Yilmaz NH, et al
    PRELIMINARY FINDINGS ON THE ROLE OF HIGH-FREQUENCY (5Hz) rTMS STIMULATION ON M1 AND Pre-SMA REGIONS IN PARKINSON'S DISEASE.
    Neurosci Lett. 2020 Feb 11:134837. doi: 10.1016/j.neulet.2020.134837.
    PubMed     Abstract available


    January 2020
  12. GAO J, Teng J, Liu Z, Cai M, et al
    Association between vitamin D receptor polymorphisms and susceptibility to Parkinson's disease: An updated meta-analysis.
    Neurosci Lett. 2020;720:134778.
    PubMed     Abstract available


    December 2019
  13. HU W, Wang L, Chen B, Wang X, et al
    Vitamin D receptor rs2228570 polymorphism and Parkinson's disease risk in a Chinese population.
    Neurosci Lett. 2019;717:134722.
    PubMed     Abstract available


  14. BI M, Kang S, Du X, Jiao Q, et al
    Association between SNCA rs356220 polymorphism and Parkinson's disease: A meta-analysis.
    Neurosci Lett. 2019;717:134703.
    PubMed     Abstract available


  15. SONG J, Lee SS, Lim S, Yeo S, et al
    Mechanism of the neuroprotective effect of injecting brain cells on ST36 in an animal model of Parkinson's disease.
    Neurosci Lett. 2019;717:134698.
    PubMed     Abstract available


    November 2019
  16. PARKHE A, Parekh P, Nalla LV, Sharma N, et al
    Protective effect of alpha mangostin on rotenone induced toxicity in rat model of Parkinson's disease.
    Neurosci Lett. 2019 Nov 25:134652. doi: 10.1016/j.neulet.2019.134652.
    PubMed     Abstract available


  17. LI X, Yang W, Li X, Chen M, et al
    Alpha-synuclein oligomerization and dopaminergic degeneration occur synchronously in the brain and colon of MPTP-intoxicated parkinsonian monkeys.
    Neurosci Lett. 2019 Nov 20:134640. doi: 10.1016/j.neulet.2019.134640.
    PubMed     Abstract available


  18. SEKAR S, Taghibiglou C
    Nuclear accumulation of GAPDH, GluA2 and p53 in Post-mortem Substantia Nigral region of Patients with Parkinson's Disease.
    Neurosci Lett. 2019 Nov 20:134641. doi: 10.1016/j.neulet.2019.134641.
    PubMed     Abstract available


  19. KATAYAMA T, Sawada J, Kikuchi-Takeguchi S, Kano K, et al
    Cerebrospinal fluid levels of alpha-synuclein, amyloid beta, tau, phosphorylated tau, and neuron-specific enolase in patients with Parkinson's disease, dementia with Lewy bodies or other neurological disorders: Their relationships with cognition and n
    Neurosci Lett. 2019 Nov 13:134564. doi: 10.1016/j.neulet.2019.134564.
    PubMed     Abstract available


  20. CHEN W, Yan X, Lv H, Liu Y, et al
    Gender differences in prevalence of LRRK2-associated Parkinson diseaseA meta-analysis of observational studies.
    Neurosci Lett. 2019 Nov 4:134609. doi: 10.1016/j.neulet.2019.134609.
    PubMed     Abstract available


    October 2019
  21. ZHANG Y, Chen J, Xu C, Feng J, et al
    Effects of glucocerebrosidase gene polymorphisms and mutations on the risk of Parkinson's disease dementia: a meta-analysis.
    Neurosci Lett. 2019 Oct 28:134544. doi: 10.1016/j.neulet.2019.134544.
    PubMed     Abstract available


  22. IWAOKA K, Otsuka C, Maeda T, Yamahara K, et al
    Impaired metabolism of kynurenine and its metabolites in CSF of Parkinson's disease.
    Neurosci Lett. 2019 Oct 22:134576. doi: 10.1016/j.neulet.2019.134576.
    PubMed     Abstract available


  23. FINE JM, Stroebel BM, Faltesek KA, Terai K, et al
    Intranasal delivery of low-dose insulin ameliorates motor dysfunction and dopaminergic cell death in a 6-OHDA rat model of Parkinson's Disease.
    Neurosci Lett. 2019;714:134567.
    PubMed     Abstract available


    September 2019
  24. SHARMA S, Awasthi A, Singh S
    Altered Gut Microbiota and Intestinal Permeability in Parkinson's disease: Pathological highlight to Management.
    Neurosci Lett. 2019 Sep 24:134516. doi: 10.1016/j.neulet.2019.134516.
    PubMed     Abstract available


    August 2019
  25. XIE SP, Zhou F, Li J, Duan SJ, et al
    NEAT1 regulates MPP(+)-induced neuronal injury by targeting miR-124 in neuroblastoma cells.
    Neurosci Lett. 2019;708:134340.
    PubMed     Abstract available


  26. MORIYA S, Tan VP, Yee AK, Parhar IS, et al
    pink1, atp13a2 and uchl1 expressions are affected by inflammation in the brain.
    Neurosci Lett. 2019;708:134330.
    PubMed     Abstract available


  27. TEJERA-PARRADO C, Jesus S, Perinan MT, Buiza-Rueda D, et al
    A replication study of GWAS-genetic risk variants associated with Parkinson's disease in a Spanish population.
    Neurosci Lett. 2019 Aug 17:134425. doi: 10.1016/j.neulet.2019.134425.
    PubMed     Abstract available


  28. BANDOOKWALA M, Kumar Sahu A, Thakkar D, Sharma M, et al
    Edaravone-caffeine combination for the effective management of rotenone induced Parkinson's disease in rats: An evidence based affirmative from a comparative analysis of behavior and biomarker expression.
    Neurosci Lett. 2019 Aug 15:134438. doi: 10.1016/j.neulet.2019.134438.
    PubMed     Abstract available


    July 2019
  29. GUIMARAES MARQUES MJ, Real CC, Balduino Victorino D, Britto LR, et al
    Endogenous protection against the 6-OHDA model of Parkinson's disease in the Amazonian rodent Proechimys.
    Neurosci Lett. 2019 Jul 17:134381. doi: 10.1016/j.neulet.2019.134381.
    PubMed     Abstract available


  30. HOU B, Zhang X, Liu Z, Wang J, et al
    Association of rs356219 and rs3822086 polymorphisms with the risk of Parkinson's disease: a meta-analysis.
    Neurosci Lett. 2019 Jul 17:134380. doi: 10.1016/j.neulet.2019.134380.
    PubMed     Abstract available


  31. KRISHNAMOORTHY A, Sevanan M, Mani S, Balu M, et al
    Chrysin restores MPTP induced neuroinflammation, oxidative stress and neurotrophic factors in an acute Parkinson's disease mouse model.
    Neurosci Lett. 2019 Jul 17:134382. doi: 10.1016/j.neulet.2019.134382.
    PubMed     Abstract available


  32. SHI K, Liu X, Hou L, Qiao D, et al
    Effects of exercise on mGluR-mediated glutamatergic transmission in the striatum of hemiparkinsonian rats.
    Neurosci Lett. 2019;705:143-150.
    PubMed     Abstract available


  33. HU F, Duan M, Peng N
    Knockdown of TRB3 improved the MPP(+)/MPTP-induced Parkinson's disease through the MAPK and AKT signaling pathways.
    Neurosci Lett. 2019;709:134352.
    PubMed     Abstract available


    June 2019
  34. MEDEIROS COSTA C, de Oliveira GL, Sousa Fonseca AC, de Carvalho Lana R, et al
    Levels of cortisol and neurotrophic factor brain-derived in Parkinson's disease.
    Neurosci Lett. 2019 Jun 29:134359. doi: 10.1016/j.neulet.2019.134359.
    PubMed     Abstract available


  35. RABENSTEIN M, Besong Agbo D, Wolf E, Dams J, et al
    Effect of naturally occurring alpha-synuclein-antibodies on toxic alpha-synuclein-fragments.
    Neurosci Lett. 2019;704:181-188.
    PubMed     Abstract available


  36. BUARD I, Dewispelaere WD, Teale P, Rojas DC, et al
    Auditory Entrainment of Motor Responses in Older Adults with and without Parkinson's disease: an MEG study.
    Neurosci Lett. 2019 Jun 18:134331. doi: 10.1016/j.neulet.2019.134331.
    PubMed     Abstract available


  37. LI F, Wang P, Chen Z, Sui X, et al
    Alteration of the fecal microbiota in North-eastern Han Chinese population with sporadic Parkinson's disease.
    Neurosci Lett. 2019 Jun 11:134297. doi: 10.1016/j.neulet.2019.134297.
    PubMed     Abstract available


  38. HENDERSON MX, Trojanowski JQ, Lee VM
    alpha-Synuclein Pathology in Parkinson's Disease and Related alpha-Synucleinopathies.
    Neurosci Lett. 2019 Jun 3:134316. doi: 10.1016/j.neulet.2019.134316.
    PubMed     Abstract available


  39. LIU B, Luo W, Mo Y, Wei C, et al
    Meta-analysis of related factors of impulse control disorders in patients with Parkinson's disease.
    Neurosci Lett. 2019 Jun 2:134313. doi: 10.1016/j.neulet.2019.134313.
    PubMed     Abstract available


    May 2019
  40. HEMMATI-DINARVAND M, Saedi S, Valilo M, Kalantary-Charvadeh A, et al
    Oxidative stress and Parkinson's disease: conflict of oxidant-antioxidant systems.
    Neurosci Lett. 2019 May 30:134296. doi: 10.1016/j.neulet.2019.134296.
    PubMed     Abstract available


  41. DEL FABBRO L, Rossito Goes A, Jesse CR, de Gomes MG, et al
    Chrysin protects against behavioral, cognitive and neurochemical alterations in a 6-hydroxydopamine model of Parkinson's disease.
    Neurosci Lett. 2019 May 20. pii: S0304-3940(19)30354.
    PubMed     Abstract available


  42. ZHENG J, Zang Q, Hu F, Wei H, et al
    Alpha-synuclein gene polymorphism affects risk of dementia in Han Chinese with Parkinson's disease.
    Neurosci Lett. 2019;706:146-150.
    PubMed     Abstract available


  43. HERAVI M, Dargahi L, Parsafar S, Tayaranian Marvian A, et al
    The primary neuronal cells are more resistant than PC12 cells to alpha-synuclein toxic aggregates.
    Neurosci Lett. 2019;701:38-47.
    PubMed     Abstract available


  44. BOROS FA, Torok R, Vagvolgyi-Sumegi E, Pesei Z, et al
    Assessment of risk factor variants of LRRK2, MAPT, SNCA and TCEANC2 genes in Hungarian sporadic Parkinson's disease patients.
    Neurosci Lett. 2019 May 11. pii: S0304-3940(19)30332.
    PubMed     Abstract available


  45. HU J, Xiao C, Gong D, Qiu C, et al
    Regional homogeneity analysis of major Parkinson's disease subtypes based on functional magnetic resonance imaging.
    Neurosci Lett. 2019 May 11. pii: S0304-3940(19)30331.
    PubMed     Abstract available


  46. FOLLETT J, Fox JD, Gustavsson EK, Kadgien C, et al
    DNAJC13 p.Asn855Ser, implicated in familial parkinsonism, alters membrane dynamics of Sorting Nexin 1.
    Neurosci Lett. 2019 May 10. pii: S0304-3940(19)30285.
    PubMed     Abstract available


  47. GHOSH A, Sadhukhan T, Giri S, Biswas A, et al
    Dopamine beta Hydroxylase (DBH) is a potential modifier gene associated with Parkinson's disease in Eastern India.
    Neurosci Lett. 2019 May 10. pii: S0304-3940(19)30333.
    PubMed     Abstract available


  48. DONG X, Zheng D, Nao J
    Measurement of serum cystatin C: A valuable tool for evaluating dyskinesia in Parkinson's disease.
    Neurosci Lett. 2019;705:172-176.
    PubMed     Abstract available


    April 2019
  49. FATIMA A, Rahul, Siddique YH
    Role of tangeritin against cognitive impairments in transgenic Drosophila model of Parkinson's disease.
    Neurosci Lett. 2019;705:112-117.
    PubMed     Abstract available


  50. ZHANG J, Jia G, Yang Z, Liu D, et al
    Impact of subthalamic nucleus stimulation did not differ on young-onset and older-onset Parkinson's disease: A three-year follow up.
    Neurosci Lett. 2019;705:99-105.
    PubMed     Abstract available


  51. ZHONG J, Guan X, Zhong X, Cao F, et al
    Levodopa imparts a normalizing effect on default-mode network connectivity in non-demented Parkinson's disease.
    Neurosci Lett. 2019 Apr 23. pii: S0304-3940(19)30284.
    PubMed     Abstract available


  52. MILLER S, Muqit MMK
    Therapeutic Approaches To Enhance PINK1/Parkin Mediated Mitophagy For The Treatment Of Parkinson's Disease.
    Neurosci Lett. 2019 Apr 14. pii: S0304-3940(19)30263.
    PubMed     Abstract available


  53. PAPAGIANNAKIS N, Xilouri M, Koros C, Simitsi AM, et al
    Autophagy dysfunction in peripheral blood mononuclear cells of Parkinson's disease patients.
    Neurosci Lett. 2019;704:112-115.
    PubMed     Abstract available


  54. MA LY, Gao LY, Li X, Ma HZ, et al
    Nitrated alpha-synuclein in minor salivary gland biopsies in Parkinson's disease.
    Neurosci Lett. 2019 Apr 1. pii: S0304-3940(19)30226.
    PubMed     Abstract available


    March 2019
  55. SUSAN B, James R, Bonnie R, Joseph H, et al
    Neuroprotective effects of acetyl-L-carnitine (ALC) in a chronic MPTP-induced Parkinson's disease mouse model: Endothelial and microglial effects.
    Neurosci Lett. 2019 Mar 16. pii: S0304-3940(19)30170.
    PubMed     Abstract available


  56. WANG L, Li NN, Lu ZJ, Li JY, et al
    Association of three candidate genetic variants in ACMSD/TMEM163, GPNMB and BCKDK /STX1B with sporadic Parkinson's disease in Han Chinese.
    Neurosci Lett. 2019 Mar 14. pii: S0304-3940(19)30173.
    PubMed     Abstract available


    February 2019
  57. WANG Z, Sun L, Jia K, Wang H, et al
    miR-9-5p modulates the progression of Parkinson's disease by targeting SIRT1.
    Neurosci Lett. 2019 Feb 28. pii: S0304-3940(19)30130.
    PubMed     Abstract available


  58. GUDUCU C, Eskicioglu E, Oz D, Oniz A, et al
    Auditory Brain Oscillatory Responses in Drug-naive Patients with Parkinson's Disease.
    Neurosci Lett. 2019 Feb 28. pii: S0304-3940(19)30131.
    PubMed     Abstract available


  59. WANG X, Shen N, Lu Y, Tan K, et al
    Vitamin D receptor polymorphisms and the susceptibility of Parkinson's disease.
    Neurosci Lett. 2019 Feb 11. pii: S0304-3940(19)30101.
    PubMed     Abstract available


  60. GUNAYDIN C, Avci B, Bozkurt A, Onger ME, et al
    Effects of Agomelatine in Rotenone-induced Parkinson's Disease in Rats.
    Neurosci Lett. 2019 Feb 1. pii: S0304-3940(19)30075.
    PubMed     Abstract available


    January 2019
  61. KAWAMURA M, Sato S, Matsumoto G, Fukuda T, et al
    Loss of nuclear REST/NRSF in aged-dopaminergic neurons in Parkinson's disease patients.
    Neurosci Lett. 2019 Jan 23. pii: S0304-3940(19)30054.
    PubMed     Abstract available


    December 2018
  62. CAO Z, Wu Y, Liu G, Jiang Y, et al
    alpha-Synuclein in salivary extracellular vesicles as a potential biomarker of Parkinson's disease.
    Neurosci Lett. 2018;696:114-120.
    PubMed     Abstract available


  63. WANG S, Li N, Zou H, Wu M, et al
    Gut microbiome-based secondary metabolite biosynthetic gene clusters detection in Parkinson's disease.
    Neurosci Lett. 2018 Dec 17. pii: S0304-3940(18)30866.
    PubMed     Abstract available


  64. BUENO MEB, do Nascimento Neto LI, Terra MB, Barboza NM, et al
    Effectiveness of acute transcranial direct current stimulation on non-motor and motor symptoms in Parkinson's disease.
    Neurosci Lett. 2018;696:46-51.
    PubMed     Abstract available


  65. ALIZADEH R, Kamrava SK, Bagher Z, Farhadi M, et al
    Human olfactory stem cells: As a promising source of dopaminergic neuron-like cells for treatment of Parkinson's disease.
    Neurosci Lett. 2018;696:52-59.
    PubMed     Abstract available


    November 2018
  66. ZAMPIER VC, Vitorio R, Beretta VS, Jaimes DAR, et al
    Gait bradykinesia and hypometria decrease as arm swing frequency and amplitude increase.
    Neurosci Lett. 2018;687:248-252.
    PubMed     Abstract available


  67. WANG Z, Kuang P, Lin Y, Liu W, et al
    Re-expression of voltage-gated sodium channel subtype Nav1.3 in the substantia nigra after dopamine depletion.
    Neurosci Lett. 2018;687:146-152.
    PubMed     Abstract available


  68. LEVY-GIGI E, Haim-Nahum S, Hall JM, Crouse J, et al
    The interactive effect of valence and context on reversal learning in individuals with Parkinson's disease.
    Neurosci Lett. 2018 Nov 6. pii: S0304-3940(18)30751.
    PubMed     Abstract available


    October 2018
  69. MIRANDA-MORALES EG, Sandoval-Carrillo A, Castellanos-Juarez FX, Mendez-Hernandez EM, et al
    H1/H2 MAPT haplotype and Parkinson's Disease in Mexican mestizo population.
    Neurosci Lett. 2018 Oct 16. pii: S0304-3940(18)30705.
    PubMed     Abstract available


  70. PURCARO C, Vanacore N, Moret F, Di Battista ME, et al
    DAT gene polymorphisms (rs28363170, rs393795) and levodopa-induced dyskinesias in Parkinson's disease.
    Neurosci Lett. 2018 Oct 11. pii: S0304-3940(18)30697.
    PubMed     Abstract available


  71. SHISHIDO T, Nagano Y, Araki M, Kurashige T, et al
    Synphilin-1 has neuroprotective effects on MPP(+)-induced Parkinson's disease model cells by inhibiting ROS production and apoptosis.
    Neurosci Lett. 2018 Oct 11. pii: S0304-3940(18)30696.
    PubMed     Abstract available


  72. FONSECA-FONSECA LA, Wong-Guerra M, Ramirez-Sanchez J, Montano-Peguero Y, et al
    JM-20, a novel hybrid molecule, protects against rotenone-induced neurotoxicity in experimental model of Parkinson's disease.
    Neurosci Lett. 2018 Oct 7. pii: S0304-3940(18)30678.
    PubMed     Abstract available


    September 2018
  73. JIN L, Wan W, Wang L, Wang C, et al
    Elevated microRNA-520d-5p in the serum of patients with Parkinson's disease, possibly through regulation of cereloplasmin expression.
    Neurosci Lett. 2018 Sep 19. pii: S0304-3940(18)30640.
    PubMed     Abstract available


  74. LU J, Chen S, Shen M, He Q, et al
    Mitochondrial regulation by pyrroloquinoline quinone prevents rotenone-induced neurotoxicity in Parkinson's disease models.
    Neurosci Lett. 2018 Sep 18. pii: S0304-3940(18)30637.
    PubMed     Abstract available


  75. CACABELOS R
    Pharmacogenomics of Alzheimer's and Parkinson's diseases.
    Neurosci Lett. 2018 Sep 17. pii: S0304-3940(18)30624.
    PubMed     Abstract available


  76. CRUZ CF, Piemonte MEP, Okai-Nobrega LA, Okamoto E, et al
    Parkinson's disease does not alter automatic visual-motor coupling in postural control.
    Neurosci Lett. 2018;686:47-52.
    PubMed     Abstract available


    August 2018
  77. CHOI DJ, Kwon JK, Joe EH
    A Parkinson's disease gene, DJ-1, regulates astrogliosis through STAT3.
    Neurosci Lett. 2018;685:144-149.
    PubMed     Abstract available


  78. CHEN Y, Cao B, Chen X, Ou R, et al
    The relationship between four GWAS-identified loci in Alzheimer's disease and the risk of Parkinson's disease, amyotrophic lateral sclerosis, and multiple system atrophy.
    Neurosci Lett. 2018 Aug 22. pii: S0304-3940(18)30569.
    PubMed     Abstract available


    July 2018
  79. LI D, Song X, Huang H, Huang H, et al
    Association of Parkinson's disease-related pain with plasma interleukin-1, interleukin-6, interleukin-10, and tumour necrosis factor-alpha.
    Neurosci Lett. 2018 Jul 28. pii: S0304-3940(18)30500.
    PubMed     Abstract available


  80. GE F, Ding J, Liu Y, Lin H, et al
    Cerebrospinal fluid NFL in the differential diagnosis of parkinsonian disorders: a meta-analysis.
    Neurosci Lett. 2018 Jul 20. pii: S0304-3940(18)30503.
    PubMed     Abstract available


  81. ROSAS-HERNANDEZ H, Chigurupati S, Raymick J, Robinson B, et al
    Identification of altered microRNAs in serum of a mouse model of Parkinson's disease.
    Neurosci Lett. 2018;687:1-9.
    PubMed     Abstract available


  82. SI QQ, Yuan YS, Zhi Y, Tong Q, et al
    Plasma transferrin level correlates with the tremor-dominant phenotype of Parkinson's disease.
    Neurosci Lett. 2018;684:42-46.
    PubMed     Abstract available


    June 2018
  83. MARTIN-RODRIGUEZ JF, Mir P
    Short-afferent inhibition and cognitive impairment in Parkinson's disease: A Quantitative Review and Challenges.
    Neurosci Lett. 2018 Jun 27. pii: S0304-3940(18)30451.
    PubMed     Abstract available


  84. SHEN YT, Li JY, Yuan YS, Wang XX, et al
    Disrupted amplitude of low-frequency fluctuations and causal connectivity in Parkinson's disease with apathy.
    Neurosci Lett. 2018;683:75-81.
    PubMed     Abstract available


  85. LUCA A, Nicoletti A, Mostile G, Sciacca G, et al
    Temperament Traits And Executive Functions In Parkinson's Disease.
    Neurosci Lett. 2018 Jun 22. pii: S0304-3940(18)30443.
    PubMed     Abstract available


  86. LUOMA J, Pekkonen E, Airaksinen K, Helle L, et al
    Spontaneous sensorimotor cortical activity is suppressed by deep brain stimulation in patients with advanced Parkinson's disease.
    Neurosci Lett. 2018 Jun 22. pii: S0304-3940(18)30444.
    PubMed     Abstract available


  87. KWIATEK-MAJKUSIAK J, Geremek M, Koziorowski D, Tomasiuk R, et al
    Higher serum levels of pro-hepcidin in patients with Parkinson's disease treated with deep brain stimulation.
    Neurosci Lett. 2018 Jun 18. pii: S0304-3940(18)30434.
    PubMed     Abstract available


  88. DU G, Zhuang P, Zhang Y, Li J, et al
    Neuronal firing rate and oscillatory patterns in the basal ganglia nuclei differ from those of the ventrolateral thalamus in patients with Parkinson disease.
    Neurosci Lett. 2018;683:1-6.
    PubMed     Abstract available


  89. PING Z, Xiaomu W, Xufang X, Wenfeng C, et al
    GAPDH rs1136666 SNP indicates a high risk of Parkinson's disease.
    Neurosci Lett. 2018 Jun 7. pii: S0304-3940(18)30416.
    PubMed     Abstract available


  90. NAGARAJAN VB, Marathe PA
    Effect of montelukast in experimental model of Parkinson's disease.
    Neurosci Lett. 2018 Jun 6. pii: S0304-3940(18)30403.
    PubMed     Abstract available


    May 2018
  91. SHU L, Zhang Y, Sun Q, Pan H, et al
    SNCA REP1 and Parkinson's disease.
    Neurosci Lett. 2018 May 30. pii: S0304-3940(18)30394.
    PubMed     Abstract available


  92. KUMARI N, Agrawal S, Kumari R, Sharma D, et al
    Neuroprotective effect of IDPU (1-(7-imino-3-propyl-2,3-dihydrothiazolo [4,5-d]pyrimidin-6(7H)-yl)urea) in 6-OHDA induced rodent model of hemiparkinson's disease.
    Neurosci Lett. 2018;675:74-82.
    PubMed     Abstract available


  93. ZHANG S, Chen S, Liu A, Wan J, et al
    Inhibition of BDNF production by MPP(+) through up-regulation of miR-210-3p contributes to dopaminergic neuron damage in MPTP model.
    Neurosci Lett. 2018;675:133-139.
    PubMed     Abstract available


  94. POWELL DW, Blackmore SE, Puppa M, Lester D, et al
    Deep brain stimulation enhances movement complexity during gait in individuals with Parkinson's disease.
    Neurosci Lett. 2018 May 8. pii: S0304-3940(18)30337.
    PubMed     Abstract available


  95. BEGUM M ET, Sen D
    DOR agonist (SNC-80) exhibits anti-parkinsonian effect via downregulating UPR/oxidative stress signals and inflammatory response in vivo.
    Neurosci Lett. 2018;678:29-36.
    PubMed     Abstract available


    April 2018
  96. FANG L, Tang BS, Fan K, Wan CM, et al
    Alzheimer's disease susceptibility genes modify the risk of Parkinson disease and Parkinson's disease-associated cognitive impairment.
    Neurosci Lett. 2018 Apr 23. pii: S0304-3940(18)30305.
    PubMed     Abstract available


  97. PUPYSHEV AB, Korolenko TA, Akopyan AA, Amstislavskaya TG, et al
    Suppression of autophagy in the brain of transgenic mice with overexpression of capital A, Cyrillic53capital TE, Cyrillic-mutant alpha-synuclein as an early event at synucleinopathy progression.
    Neurosci Lett. 2018;672:140-144.
    PubMed     Abstract available


  98. WANG P, Guo Y, Song C, Liu Y, et al
    PINK1 p.K520RfsX3 Mutation Identified in a Chinese Family with Early-onset Parkinson's disease.
    Neurosci Lett. 2018 Apr 12. pii: S0304-3940(18)30283.
    PubMed     Abstract available


  99. SHEEHAN P, Yue Z
    Deregulation of autophagy and vesicle trafficking in Parkinson's disease.
    Neurosci Lett. 2018 Apr 5. pii: S0304-3940(18)30268.
    PubMed     Abstract available


  100. CHU CT
    Multiple pathways for mitophagy: A neurodegenerative conundrum for Parkinson's disease.
    Neurosci Lett. 2018 Apr 4. pii: S0304-3940(18)30259.
    PubMed     Abstract available


    March 2018
  101. CROOKS SA, Bech S, Halling J, Christiansen DH, et al
    Carnitine levels and mutations in the SLC22A5 gene in Faroes patients with Parkinson's disease.
    Neurosci Lett. 2018;675:116-119.
    PubMed     Abstract available


  102. LI W, Jiang Y, Wang Y, Yang S, et al
    MiR-181b regulates autophagy in a model of Parkinson's disease by targeting the PTEN/Akt/mTOR signaling pathway.
    Neurosci Lett. 2018;675:83-88.
    PubMed     Abstract available


  103. SADHUKHAN D, Das G, Biswas A, Ghosh S, et al
    Evaluation of FGF 20 variants for susceptibility to Parkinson's disease in Eastern Indians.
    Neurosci Lett. 2018 Mar 28. pii: S0304-3940(18)30236.
    PubMed     Abstract available


  104. GENG L, Zhang T, Liu W, Chen Y, et al
    miR-494-3p modulates the progression of in vitro and in vivo Parkinson's disease models by targeting SIRT3.
    Neurosci Lett. 2018;675:23-30.
    PubMed     Abstract available


  105. HOU Y, Luo C, Yang J, Ou R, et al
    Altered intrinsic brain functional connectivity in drug-naive Parkinson's disease patients with LRRK2 mutations.
    Neurosci Lett. 2018 Mar 19. pii: S0304-3940(18)30215.
    PubMed     Abstract available


  106. MAPLE-GRODEM J, Chung J, Lunde KA, Tzoulis C, et al
    Alzheimer disease associated variants in SORL1 accelerate dementia development in Parkinson disease.
    Neurosci Lett. 2018;674:123-126.
    PubMed     Abstract available


  107. WATANABE T, Saito K, Ishida K, Tanabe S, et al
    Effect of auditory stimulus on executive function and execution time during cognitively demanding stepping task in patients with Parkinson's disease.
    Neurosci Lett. 2018 Mar 17. pii: S0304-3940(18)30209.
    PubMed     Abstract available


  108. POCHMANN D, Peccin PK, da Silva IRV, Dorneles GP, et al
    Cytokine modulation in response to acute and chronic aquatic therapy intervention in Parkinson disease individuals: A pilot study.
    Neurosci Lett. 2018 Mar 11. pii: S0304-3940(18)30190.
    PubMed     Abstract available


  109. JIN H, Chen J, Li K, Zhang JR, et al
    A novel p.L216I mutation in the glucocerebrosidase gene is associated with Parkinson's disease in Han Chinese patients.
    Neurosci Lett. 2018 Mar 9. pii: S0304-3940(18)30186.
    PubMed     Abstract available


    February 2018
  110. GUO T, Guan X, Zeng Q, Xuan M, et al
    Correlations between CSF proteins and spontaneous neuronal activity in Parkinson's disease.
    Neurosci Lett. 2018;673:61-66.
    PubMed     Abstract available


  111. DUTTA P, Dargahi L, O'Connell KE, Bolia A, et al
    A novel modelling mechanism of PAEL receptor and GABARAPL2 interaction involved in Parkinson's disease.
    Neurosci Lett. 2018;673:12-18.
    PubMed     Abstract available


  112. DI NATALE C, Monaco A, Pedone C, Tessitore A, et al
    THE LEVEL OF 24-HYDROXYCHOLESTERYL ESTERS DECREASES IN PLASMA OF PATIENTS WITH PARKINSON'S DISEASE.
    Neurosci Lett. 2018 Feb 24. pii: S0304-3940(18)30123.
    PubMed     Abstract available


  113. JIANG X, Wang X, Tuo M, Ma J, et al
    RAGE and its emerging role in the pathogenesis of Parkinson's disease.
    Neurosci Lett. 2018 Feb 22. pii: S0304-3940(18)30131.
    PubMed     Abstract available


  114. ZHENG X, Chen X, Guo M, Ali S, et al
    Changes in salsolinol production and salsolinol synthase activity in Parkinson's disease model.
    Neurosci Lett. 2018 Feb 15. pii: S0304-3940(18)30100.
    PubMed     Abstract available


  115. GOMEZ G, Saborido MD, Bernardi MA, Gershanik OS, et al
    Regulation of Pleiotrophin and Fyn in the striatum of rats undergoing L-DOPA-induced dyskinesia.
    Neurosci Lett. 2018;666:5-10.
    PubMed     Abstract available


  116. SILVEIRA CRA, Roy EA, Almeida QJ
    Acute effects of aerobic exercise on cognitive function in individuals with Parkinson's disease.
    Neurosci Lett. 2018 Feb 3. pii: S0304-3940(18)30068.
    PubMed     Abstract available


    January 2018
  117. MAO W, Zhao C, Ding H, Liang K, et al
    Pyrosequencing analysis of methylation levels of clock genes in leukocytes from Parkinson's disease patients.
    Neurosci Lett. 2018;668:115-119.
    PubMed     Abstract available


  118. WANG X, Li J, Wang M, Yuan Y, et al
    Alterations of the amplitude of low-frequency fluctuations in anxiety in Parkinson's disease.
    Neurosci Lett. 2018;668:19-23.
    PubMed     Abstract available


  119. MOON HC, Won SY, Kim EG, Kim HK, et al
    Effect of optogenetic modulation on entopeduncular input affects thalamic discharge and behavior in an AAV2-alpha-synuclein-induced hemiparkinson rat model.
    Neurosci Lett. 2018;662:129-135.
    PubMed     Abstract available


  120. ZHENG Q, Huang C, Guo J, Tan J, et al
    Hsp70 participates in PINK1-mediated mitophagy by regulating the stability of PINK1.
    Neurosci Lett. 2018;662:264-270.
    PubMed     Abstract available


    December 2017
  121. SEKAR S, Taghibiglou C
    Elevated nuclear phosphatase and tensin homolog (PTEN) and altered insulin signaling in substantia nigral region of patients with Parkinson's disease.
    Neurosci Lett. 2017;666:139-143.
    PubMed     Abstract available


  122. WANG L, Nie K, Zhao X, Feng S, et al
    Characteristics of gray matter morphological change in Parkinson's disease patients with semantic abstract reasoning deficits.
    Neurosci Lett. 2017 Dec 21. pii: S0304-3940(17)31020.
    PubMed     Abstract available


  123. CHENG Y, Mao CY, Liu YT, Li F, et al
    Analysis of variant rs3794087 in SLC1A2 and Parkinson's disease in a Chinese Han population: a case-control study and meta-analysis.
    Neurosci Lett. 2017 Dec 21. pii: S0304-3940(17)31018.
    PubMed     Abstract available


  124. HARRISON IF, Smith AD, Dexter DT
    Pathological histone acetylation in Parkinson's disease: Neuroprotection and inhibition of microglial activation through SIRT 2 inhibition.
    Neurosci Lett. 2017;666:48-57.
    PubMed     Abstract available


  125. AN C, Pu X, Xiao W, Zhang H, et al
    Expression of the DJ-1 protein in the serum of Chinese patients with Parkinson's disease.
    Neurosci Lett. 2017;665:236-239.
    PubMed     Abstract available


  126. BREZA M, Koutsis G, Karadima G, Potagas C, et al
    The different faces of the p. A53T alpha-synuclein mutation: a screening of Greek patients with parkinsonism and/or dementia.
    Neurosci Lett. 2017 Dec 9. pii: S0304-3940(17)30988.
    PubMed     Abstract available


    November 2017
  127. LI XR, Ren YD, Cao B, Huang XL, et al
    Analysis of white matter characteristics with tract-based spatial statistics according to diffusion tensor imaging in early Parkinson's disease.
    Neurosci Lett. 2017 Nov 30. pii: S0304-3940(17)30973.
    PubMed     Abstract available


  128. DU K, Liu MY, Pan YZ, Zhong X, et al
    Association of circulating manganese levels with Parkinson's disease: A meta-analysis.
    Neurosci Lett. 2017;665:92-98.
    PubMed     Abstract available


  129. CAI M, Liu Z, Li W, Wang Y, et al
    Association between rs823128 polymorphism and the risk of Parkinson's disease: A meta-analysis.
    Neurosci Lett. 2017 Nov 27. pii: S0304-3940(17)30966.
    PubMed     Abstract available


  130. PAPAGIANNAKIS N, Koros C, Stamelou M, Simitsi AM, et al
    Alpha-synuclein dimerization in erythrocytes of patients with genetic and non-genetic forms of Parkinson's Disease.
    Neurosci Lett. 2017 Nov 9. pii: S0304-3940(17)30910.
    PubMed     Abstract available


  131. YUAN XQ, Cao B, Wu Y, Chen YP, et al
    Association analysis of SNP rs11868035 in SREBF1 with sporadic Parkinson's disease, sporadic amyotrophic lateral sclerosis and multiple system atrophy in a Chinese population.
    Neurosci Lett. 2017 Nov 8. pii: S0304-3940(17)30913.
    PubMed     Abstract available


    October 2017
  132. LIU L, Zhang L, Guo L, Yu Q, et al
    MTHFR C677T and A1298C polymorphisms may contribute to the risk of Parkinson's disease: A meta-analysis of 19 studies.
    Neurosci Lett. 2017;662:339-345.
    PubMed     Abstract available


  133. WU Q, Gao Y, Liu AS, Xie LZ, et al
    Large-scale cortical volume correlation networks reveal disrupted small world patterns in Parkinson's disease.
    Neurosci Lett. 2017 Oct 20. pii: S0304-3940(17)30858.
    PubMed     Abstract available


  134. MATSUURA K, Kajikawa H, Tabei KI, Satoh M, et al
    The effectiveness of istradefylline for the treatment of gait deficits and sleepiness in patients with Parkinson's disease.
    Neurosci Lett. 2017 Oct 12. pii: S0304-3940(17)30836.
    PubMed     Abstract available


    September 2017
  135. KONG P, Lei P, Zhang S, Li D, et al
    Integrated microarray analysis provided a new insight of the pathogenesis of Parkinson's disease.
    Neurosci Lett. 2017 Sep 28. pii: S0304-3940(17)30793.
    PubMed     Abstract available


  136. GMITTEROVA K, Gawinecka J, Heinemann U, Valkovic P, et al
    DNA versus RNA oxidation in Parkinson's disease: which is more important?
    Neurosci Lett. 2017 Sep 26. pii: S0304-3940(17)30790.
    PubMed     Abstract available


  137. ABBAOUI A, Chatoui H, Hiba OE, Gamrani H, et al
    Neuroprotective effect of curcumin-I in copper-induced dopaminergic neurotoxicity in rats: A possible link with Parkinson's disease.
    Neurosci Lett. 2017 Sep 14. pii: S0304-3940(17)30774.
    PubMed     Abstract available


  138. XI J, Yang X, Zhao Q, Zheng J, et al
    Absence of association of the Ala58Val (rs17571) CTSD gene variant with Parkinson's disease or amyotrophic lateral sclerosis in a Han Chinese population.
    Neurosci Lett. 2017 Sep 13. pii: S0304-3940(17)30771.
    PubMed     Abstract available


  139. FLACH A, Jaegers L, Krieger M, Bixler E, et al
    Endurance Exercise Improves Function in Individuals with Parkinson's Disease: A Meta-analysis.
    Neurosci Lett. 2017 Sep 1. pii: S0304-3940(17)30733.
    PubMed     Abstract available


    August 2017
  140. CAO H, Shi J, Cao B, Kang B, et al
    Evaluation of the Braak staging of brain pathology with 1H-MRS in patients with Parkinson's disease.
    Neurosci Lett. 2017 Aug 24. pii: S0304-3940(17)30697.
    PubMed     Abstract available


  141. LINDENAU JD, Altmann V, Schumacher-Schuh AF, Rieder CR, et al
    Tumor necrosis factor alpha polymorphisms are associated with Parkinson's disease age at onset.
    Neurosci Lett. 2017 Aug 24. pii: S0304-3940(17)30696.
    PubMed     Abstract available


  142. FANG J, Hou B, Liu H, Zhang X, et al
    Association between SNCA rs2736990 polymorphism and Parkinson's disease: a meta-analysis.
    Neurosci Lett. 2017;658:102-107.
    PubMed     Abstract available


  143. LUDTMANN MHR, Abramov AY
    Mitochondrial calcium imbalance in Parkinson's disease.
    Neurosci Lett. 2017 Aug 21. pii: S0304-3940(17)30691.
    PubMed     Abstract available


  144. BERGE-SEIDL V, Pihlstrom L, Maple-Grodem J, Forsgren L, et al
    The GBA variant E326K is associated with Parkinson's disease and explains a genome-wide association signal.
    Neurosci Lett. 2017 Aug 19. pii: S0304-3940(17)30687.
    PubMed     Abstract available


  145. GAO Y, Nie K, Huang B, Mei M, et al
    Changes of brain structure in Parkinson's disease patients with mild cognitive impairment analyzed via VBM technology.
    Neurosci Lett. 2017 Aug 17. pii: S0304-3940(17)30675.
    PubMed     Abstract available


  146. LV W, Guan Q, Hu X, Chen J, et al
    Vestibulo-ocular reflex abnormality in Parkinson's disease detected by video head impulse test.
    Neurosci Lett. 2017 Aug 11. pii: S0304-3940(17)30668.
    PubMed     Abstract available


  147. HE T, Wang J, Wang X, Deng W, et al
    Association between PARK16 and Parkinson's disease: a meta-analysis.
    Neurosci Lett. 2017 Aug 11. pii: S0304-3940(17)30669.
    PubMed     Abstract available


  148. XIAO H, Li M, Cai J, Li N, et al
    Selective cholinergic depletion of pedunculopontine tegmental nucleus aggravates freezing of gait in parkinsonian rats.
    Neurosci Lett. 2017 Aug 10. pii: S0304-3940(17)30663.
    PubMed     Abstract available


  149. FANG J, Chen H, Cao Z, Jiang Y, et al
    Impaired Brain Network Architecture in Newly Diagnosed Parkinson's Disease Based on Graph Theoretical Analysis.
    Neurosci Lett. 2017 Aug 5. pii: S0304-3940(17)30638.
    PubMed     Abstract available


    July 2017
  150. RINGMAN JM, Casado M, Van Berlo V, Pa J, et al
    A novel PSEN1 (S230N) mutation causing early-onset Alzheimer's Disease associated with prosopagnosia, hoarding, and Parkinsonism.
    Neurosci Lett. 2017 Jul 29. pii: S0304-3940(17)30618.
    PubMed     Abstract available


  151. WEILAN Y, Weiguo Y, Baisheng H, Lixiang W, et al
    Neuroprotective Effects of Lentivirus-mediated Cystathionine-beta-synthase Overexpression against 6-OHDA-induced Parkinson's Disease Rats.
    Neurosci Lett. 2017 Jul 29. pii: S0304-3940(17)30581.
    PubMed     Abstract available


  152. LI X, Xue L, Sun J, Sun Y, et al
    Single nucleotide polymorphisms in the toll-like receptor 2 (TLR2) gene are associated with sporadic Parkinson's disease in the North-eastern Han Chinese population.
    Neurosci Lett. 2017;656:72-76.
    PubMed     Abstract available


  153. REED-JONES RJ, Powell DW
    The effects of gaze stabilization on gait parameters in individuals with Parkinson's disease.
    Neurosci Lett. 2017 Jul 11. pii: S0304-3940(17)30573.
    PubMed     Abstract available


  154. YAO Z, Shao Y, Han X
    Freezing of gait is associated with cognitive impairment in patients with Parkinson disease.
    Neurosci Lett. 2017 Jul 8. pii: S0304-3940(17)30555.
    PubMed     Abstract available


    June 2017
  155. DIBILIO V, Nicoletti A, Mostile G, Portaro G, et al
    Computer-Assisted Cognitive Rehabilitation on Freezing of Gait in Parkinson's Disease: A Pilot Study.
    Neurosci Lett. 2017 Jun 9. pii: S0304-3940(17)30486.
    PubMed     Abstract available


  156. HE D, Hu P, Deng X, Song Z, et al
    Genetic analysis of the RIC3 gene in Han Chinese patients with Parkinson's disease.
    Neurosci Lett. 2017 Jun 9. pii: S0304-3940(17)30487.
    PubMed     Abstract available


  157. WANG X, Zhang J, Yuan Y, Li T, et al
    Cerebral metabolic change in Parkinson's disease patients with anxiety: A FDG-PET study.
    Neurosci Lett. 2017;653:202-207.
    PubMed     Abstract available


  158. SHIN JH, Shin SA, Lee JY, Nam H, et al
    Precuneus degeneration and isolated apathy in patients with Parkinson's disease.
    Neurosci Lett. 2017;653:250-257.
    PubMed     Abstract available


    May 2017
  159. HAO Y, Shabanpoor A, Metz GA
    Stress and corticosterone alter synaptic plasticity in a rat model of Parkinson's disease.
    Neurosci Lett. 2017;651:79-87.
    PubMed     Abstract available


    April 2017
  160. PENG B, Wang S, Zhou Z, Liu Y, et al
    A multilevel-ROI-features-based machine learning method for detection of morphometric biomarkers in Parkinson's disease.
    Neurosci Lett. 2017 Apr 20. pii: S0304-3940(17)30335.
    PubMed     Abstract available


  161. LIU H, Liu H, Li T, Cui J, et al
    NR4A2 genetic variation and Parkinson's disease: evidence from a systematic review and meta-analysis.
    Neurosci Lett. 2017 Apr 3. pii: S0304-3940(17)30090.
    PubMed     Abstract available


  162. YANG X, Zheng J, An R, Tian S, et al
    Polymorphism in MIR4697 but not VPS13C, GCH1, or SIPA1L2 is associated with risk of Parkinson's disease in a Han Chinese population.
    Neurosci Lett. 2017 Apr 2. pii: S0304-3940(17)30287.
    PubMed     Abstract available


    March 2017
  163. CHEN S, Liu Y, Niu Y, Xu Y, et al
    Increased abundance of myeloid-derived suppressor cells and Th17 cells in peripheral blood of newly-diagnosed Parkinson's disease patients.
    Neurosci Lett. 2017 Mar 27. pii: S0304-3940(17)30275.
    PubMed     Abstract available


  164. KUMARI N, Agrawal S, Luthra PM
    Pharmacological assessments of potent A2A receptor antagonist IDPU (1-(7-imino-3-propyl-2,3-dihydrothiazolo[4,5-d]pyrimidin-6(7H)-yl)urea) in rodent model of haloperidol induced Parkinson like symptoms.
    Neurosci Lett. 2017;647:53-60.
    PubMed     Abstract available


  165. DEMETER G, Valalik I, Pajkossy P, Szollosi A, et al
    The effect of deep brain stimulation of the subthalamic nucleus on executive functions: Impaired verbal fluency and intact updating, planning and conflict resolution in Parkinson's disease.
    Neurosci Lett. 2017 Mar 18. pii: S0304-3940(17)30247.
    PubMed     Abstract available


  166. WANG L, Huang J, Pang S, Qin X, et al
    Genetic analysis of the ATG16L1 gene promoter in sporadic Parkinson's disease.
    Neurosci Lett. 2017;646:30-35.
    PubMed     Abstract available


    February 2017
  167. TANG Y, Meng L, Wan CM, Liu ZH, et al
    Identifying the presence of Parkinson's disease using low-frequency fluctuations in BOLD signals.
    Neurosci Lett. 2017 Feb 26. pii: S0304-3940(17)30172.
    PubMed     Abstract available


  168. CAO XY, Lu JM, Zhao ZQ, Li MC, et al
    MicroRNA biomarkers of Parkinson's disease in serum exosome-like microvesicles.
    Neurosci Lett. 2017 Feb 18. pii: S0304-3940(17)30161.
    PubMed     Abstract available


  169. TANAKA K, Miyake Y, Fukushima W, Kiyohara C, et al
    Vitamin D receptor gene polymorphisms, smoking, and risk of sporadic Parkinson's disease in Japan.
    Neurosci Lett. 2017;643:97-102.
    PubMed     Abstract available


  170. FATHALLA AM, Soliman AM, Moustafa AA
    Selective A2A receptors blockade reduces degeneration of substantia nigra dopamine neurons in a rotenone-induced rat model of Parkinson's disease: A histological study.
    Neurosci Lett. 2017;643:89-96.
    PubMed     Abstract available


  171. MIKI Y, Tanji K, Mori F, Kakita A, et al
    PLA2G6 accumulates in Lewy bodies in PARK14 and idiopathic Parkinson's disease.
    Neurosci Lett. 2017 Feb 14. pii: S0304-3940(17)30133.
    PubMed     Abstract available


  172. LI Y, Huang J, Pang S, Wang H, et al
    Novel and functional ATG12 gene variants in sporadic Parkinson's disease.
    Neurosci Lett. 2017 Feb 13. pii: S0304-3940(17)30134.
    PubMed     Abstract available


  173. TIAN S, Yang X, Zhao Q, Zheng J, et al
    Association between a heme oxygenase-2 genetic variant and risk of Parkinson's disease in Han Chinese.
    Neurosci Lett. 2017 Feb 5. pii: S0304-3940(17)30114.
    PubMed     Abstract available


    January 2017
  174. KANG SY, Lee SB, Kim HJ, Kim HT, et al
    Autophagic modulation by rosuvastatin prevents rotenone-induced neurotoxicity in an in vitro model of Parkinson's disease.
    Neurosci Lett. 2017 Jan 27. pii: S0304-3940(17)30091.
    PubMed     Abstract available


  175. CORBILLE AG, Preterre C, Rolli-Derkinderen M, Coron E, et al
    Biochemical analysis of alpha-synuclein extracted from control and Parkinson's disease colonic biopsies.
    Neurosci Lett. 2017 Jan 23. pii: S0304-3940(17)30070.
    PubMed     Abstract available


  176. ZHANG Y, Wu JY, Weng LH, Li XX, et al
    Valproic acid protects against MPP(+)-mediated neurotoxicity in SH-SY5Y Cells through autophagy.
    Neurosci Lett. 2017;638:60-68.
    PubMed     Abstract available


  177. BRIFFA M, Ghio S, Neuner J, Gauci AJ, et al
    Extracts from two ubiquitous Mediterranean plants ameliorate cellular and animal models of neurodegenerative proteinopathies.
    Neurosci Lett. 2017;638:12-20.
    PubMed     Abstract available


    December 2016
  178. PEZZI JC, Bem CM, Rocha TJ, Schumacher-Schuh AF, et al
    Association between DNA methyltransferase gene polymorphism and Parkinson's disease.
    Neurosci Lett. 2016 Dec 29. pii: S0304-3940(16)31006.
    PubMed     Abstract available


  179. RIAL D, Morato X, Real JI, Goncalves FQ, et al
    Parkinson's disease-associated GPR37 receptor regulates cocaine-mediated synaptic depression in corticostriatal synapses.
    Neurosci Lett. 2016;638:162-166.
    PubMed     Abstract available


  180. XIANG Y, Gong T, Wu J, Li J, et al
    Subtypes evaluation of motor dysfunction in Parkinson's disease using neuromelanin-sensitive magnetic resonance imaging.
    Neurosci Lett. 2016;638:145-150.
    PubMed     Abstract available


    November 2016
  181. XIE Y, Feng H, Peng S, Xiao J, et al
    Association of plasma homocysteine, vitamin B12 and folate levels with cognitive function in Parkinson's disease: A meta-analysis.
    Neurosci Lett. 2016 Nov 10. pii: S0304-3940(16)30846.
    PubMed     Abstract available


  182. LATTARI E, Costa SS, Campos C, de Oliveira AJ, et al
    Can transcranial direct current stimulation on the dorsolateral prefrontal cortex improves balance and functional mobility in Parkinson's disease?
    Neurosci Lett. 2016 Nov 9. pii: S0304-3940(16)30861.
    PubMed     Abstract available


  183. CAO CY, Zeng K, Li DY, Zhan SK, et al
    Modulations on cortical oscillations by Subthalamic deep brain stimulation in patients with Parkinson disease: a MEG study.
    Neurosci Lett. 2016 Nov 3. pii: S0304-3940(16)30848.
    PubMed     Abstract available


    October 2016
  184. PCHELINA S, Emelyanov A, Baydakova G, Andoskin P, et al
    Oligomeric alpha-synuclein and glucocerebrosidase activity levels in GBA-associated Parkinson's disease.
    Neurosci Lett. 2016 Oct 22. pii: S0304-3940(16)30792.
    PubMed     Abstract available


  185. ABREU GM, Valenca DC, Campos M Junior, da Silva CP, et al
    Autosomal dominant Parkinson's disease: Incidence of mutations in LRRK2, SNCA, VPS35 and GBA genes in Brazil.
    Neurosci Lett. 2016;635:67-70.
    PubMed     Abstract available


  186. DENG X, Tang CY, Zhang J, Zhu L, et al
    The cortical thickness correlates of clinical manifestations in the mid-stage sporadic Parkinson's disease.
    Neurosci Lett. 2016;633:279-289.
    PubMed     Abstract available


  187. HOU Y, Luo C, Yang J, Song W, et al
    A resting-state fMRI study on early-stage drug-naive Parkinson's disease patients with drooling.
    Neurosci Lett. 2016 Oct 4. pii: S0304-3940(16)30749.
    PubMed     Abstract available


    September 2016
  188. ZENG W, Liu F, Wang Q, Wang Y, et al
    Parkinson's disease classification using gait analysis via deterministic learning.
    Neurosci Lett. 2016 Sep 27. pii: S0304-3940(16)30726.
    PubMed     Abstract available


  189. SHI C, Li F, Yang J, Zhang S, et al
    DNAJC6 mutations are not common causes of early onset Parkinson's disease in Chinese Han population.
    Neurosci Lett. 2016 Sep 26. pii: S0304-3940(16)30727.
    PubMed     Abstract available


  190. DENG X, Li FJ, Tang CY, Zhang J, et al
    The cortical surface correlates of clinical manifestations in the mid-stage sporadic Parkinson's disease.
    Neurosci Lett. 2016 Sep 17. pii: S0304-3940(16)30707.
    PubMed     Abstract available


  191. MATSUURA K, Maeda M, Tabei KI, Umino M, et al
    A longitudinal study of neuromelanin-sensitive magnetic resonance imaging in Parkinson's disease.
    Neurosci Lett. 2016 Sep 9. pii: S0304-3940(16)30684.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: